BYR-81888-84019
4 vaccinations
4 coded responses
46 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 559 / MN
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
AGJ-22851-85794
Child or adolescent in my care · Male · 2022-08-08
QHF-21038-16087
Child or adolescent in my care · Female · 2023-01-03
Timeline
-
2021-01-06
Dose 1 — Pfizer-BioNTech
-
2021-01-09
Registered in v-safe
-
2021-01-09
Survey response — days 1–6 daily, dose 1MedDRA: Headache — Feeling: Good · Site: Pain · HeadacheFree text: Headache day of injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-10
- 2021-01-11
-
2021-01-12
Survey response — days 1–6 daily, dose 1MedDRA: Lymphadenopathy — Feeling: Good · Fatigue or tirednessFree text: Swollen lymph nodeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Survey response — day 7, dose 1MedDRA: Lymphadenopathy — Feeling: GoodFree text: Swollen lymph nodeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Survey response — day 14, dose 1MedDRA: Arthralgia, Lymphadenopathy — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Continue having shoulder pain and a swollen lymph node on the side of the injection. Not worsening but not improving either.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Report sent to call center — day 14, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-27
Dose 2 — Pfizer-BioNTech
-
2021-01-27
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-01-29
- 2021-01-31
-
2021-02-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-02-02
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-03-27
- 2021-04-28
-
2021-10-03
Dose 3 — Pfizer-BioNTech
- 2021-10-03
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-17
- 2021-10-24
- 2021-10-31
- 2021-11-07
- 2021-11-14
- 2022-01-02
- 2022-04-03
- 2022-10-03
-
2022-10-04
Dose 4 — Pfizer-BioNTech
- 2022-10-07
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-11
- 2022-10-18
- 2022-10-25
- 2022-11-03
- 2022-11-08
- 2022-11-15
- 2023-01-03
- 2023-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | |
| 2 | 2021-01-27 | Pfizer-BioNTech | |
| 3 | 2021-10-03 | Pfizer-BioNTech | No |
| 4 | 2022-10-04 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Headache day of injection
Systemic reaction (other): Swollen lymph node
Release 1 — day 7, dose 1
Systemic reaction (other): Swollen lymph node
Release 2 — day 14, dose 1
Symptoms: Continue having shoulder pain and a swollen lymph node on the side of the injection. Not worsening but not improving either.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release